NCT05728866

Brief Summary

The purpose of this research study is to understand the efficacy of using an immersive Virtual Reality (VR) environment, with task-specific training, to encourage arm movement following stroke.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
13

participants targeted

Target at below P25 for not_applicable stroke

Timeline
Completed

Started Mar 2023

Typical duration for not_applicable stroke

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 6, 2023

Completed
9 days until next milestone

First Posted

Study publicly available on registry

February 15, 2023

Completed
25 days until next milestone

Study Start

First participant enrolled

March 12, 2023

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 20, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 20, 2025

Completed
Last Updated

March 19, 2026

Status Verified

March 1, 2026

Enrollment Period

2.7 years

First QC Date

February 6, 2023

Last Update Submit

March 17, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in hemiplegic arm movements

    Arm movements will be measured using wrist-worn accelerometers. Amount of movement will be measured prior to and following the intervention

    Baseline to approximately 12 days

Study Arms (1)

Virtual reality (VR) therapy

EXPERIMENTAL
Procedure: VR immersive therapy

Interventions

Participants will be asked to participate in 5 consecutive, 1-hour, 1:1 therapy sessions focused on rehabilitation of their weakened arm. Each session will involve use of a Virtual Reality (VR) system to deliver an immersive environment to encourage movement of the arm. The system also relies on 6 body-worn sensors that will detect movements of participant's arms and trunk. VR use will encompass 30-minutes of the therapy session, the remainder of the session will involve working with the therapist in addressing the functional tasks that are most meaningful for the participant and that involve the upper extremities.

Virtual reality (VR) therapy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18 or older.
  • Diagnosed as having an ischemic or hemorrhagic stroke (with documented confirmatory neuroimaging in the medical record) that occurred at least 6-months prior to study enrollment.
  • Lack of full active range of motion in the involved shoulder, elbow, and wrist as the result of the injury.
  • At the time of study enrollment, participant completed structured therapeutic interventions at least 2-months prior.
  • Participants will not participate in Yoga, Tai-Chi, or other wellness lifestyle classes while participating in the study.
  • Absence of significant cognitive impairment as determined by a Mini-Mental Status Examination score of greater than or equal to 24.
  • The absence of upper extremity injury limiting functional use of the arm prior to the incident stroke.

You may not qualify if:

  • Unable to provide informed consent.
  • Sensory loss as determined by a score of 2 on the sensory item of the NIH Stroke Scale.
  • Pain in the involved upper limb that could interfere with daily activities as evidenced by a pain score of 5 or greater on the Numeric Pain Rating Scale.
  • History of greater than two strokes.
  • Suffered a stroke less than 6-months prior to participating in the study.
  • A history of, or being susceptible to, cyber-sickness (i.e., motion sickness).
  • Unable to don/doff accelerometer independently, or the lack of support in the home to assist with donning/doffing device; and
  • A history of seizures.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Virginia Commonwealth University

Richmond, Virginia, 23298, United States

Location

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Virginia Chu, PhD

    Virginia Commonwealth University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 6, 2023

First Posted

February 15, 2023

Study Start

March 12, 2023

Primary Completion

November 20, 2025

Study Completion

November 20, 2025

Last Updated

March 19, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations